Insider · CIK 0002111365
Andrew Cordell Schaap
Files at CHRN (EKSO BIONICS HOLDINGS, INC.). First filing -, latest -.
In brief
Andrew Cordell Schaap files SEC Form 4 as director at CHRN (EKSO BIONICS HOLDINGS, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Andrew Cordell Schaap has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 29, 2026 | CHRN EKSO BIONICS HOLDINGS, INC. | AGrant or award Common Stock | +200,000 | $0.00 | $0 | 200,000 | Jun 30, 2026 |
Questions about Andrew Cordell Schaap
Answered from the filings on this page, as of the latest one.
Is Andrew Cordell Schaap buying or selling?
Andrew Cordell Schaap has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Andrew Cordell Schaap's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Andrew Cordell Schaap has 0.
Where does Andrew Cordell Schaap file Form 4?
Andrew Cordell Schaap has filed Form 4 at CHRN (EKSO BIONICS HOLDINGS, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.